Russell Investments Group’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.07M | Buy |
350,429
+52,865
| +18% | +$724K | 0.01% | 1388 |
|
|
2026
Q1 | $3.7M | Sell |
297,564
-91,793
| -24% | -$1.23M | ﹤0.01% | 1525 |
|
|
2025
Q4 | $4.93M | Sell |
389,357
-156,673
| -29% | -$1.79M | 0.01% | 1338 |
|
|
2025
Q3 | $5.44M | Sell |
546,030
-17,052
| -3% | -$153K | 0.01% | 1260 |
|
|
2025
Q2 | $4.56M | Buy |
563,082
+79,278
| +16% | +$598K | 0.01% | 1271 |
|
|
2025
Q1 | $4.03M | Buy |
483,804
+217,877
| +82% | +$1.82M | 0.01% | 1281 |
|
|
2024
Q4 | $2.1M | Buy |
265,927
+99,807
| +60% | +$837K | ﹤0.01% | 1644 |
|
|
2024
Q3 | $1.38M | Sell |
166,120
-15,055
| -8% | -$118K | ﹤0.01% | 1881 |
|
|
2024
Q2 | $1.15M | Buy |
181,175
+5,490
| +3% | +$34.9K | ﹤0.01% | 1910 |
|
|
2024
Q1 | $1.06M | Sell |
175,685
-470,242
| -73% | -$2.65M | ﹤0.01% | 1951 |
|
|
2023
Q4 | $3.92M | Sell |
645,927
-107,457
| -14% | -$479K | 0.01% | 1250 |
|
|
2023
Q3 | $3.18M | Buy |
753,384
+744,063
| +7,983% | +$2.77M | 0.01% | 1306 |
|
|
2023
Q2 | $28.9K | Sell |
9,321
-103,155
| -92% | -$220K | ﹤0.01% | 2787 |
|
|
2023
Q1 | $156K | Sell |
112,476
-363,555
| -76% | -$724K | ﹤0.01% | 2517 |
|
|
2022
Q4 | $947K | Sell |
476,031
-41,177
| -8% | -$92.3K | ﹤0.01% | 1998 |
|
|
2022
Q3 | $1.04M | Buy |
517,208
+24,908
| +5% | +$69.8K | ﹤0.01% | 1914 |
|
|
2022
Q2 | $1.56M | Sell |
492,300
-25,945
| -5% | -$94K | ﹤0.01% | 1719 |
|
|
2022
Q1 | $2.16M | Buy |
518,245
+38,555
| +8% | +$171K | ﹤0.01% | 1604 |
|
|
2021
Q4 | $2.3M | Sell |
479,690
-142,421
| -23% | -$710K | ﹤0.01% | 1722 |
|
|
2021
Q3 | $3.32M | Buy |
622,111
+342,623
| +123% | +$1.72M | 0.01% | 1493 |
|
|
2021
Q2 | $1.43M | Buy |
279,488
+138,305
| +98% | +$786K | ﹤0.01% | 2134 |
|
|
2021
Q1 | $949K | Sell |
141,183
-27,151
| -16% | -$150K | ﹤0.01% | 2266 |
|
|
2020
Q4 | $768K | Buy |
168,334
+91,526
| +119% | +$406K | ﹤0.01% | 2239 |
|
|
2020
Q3 | $297K | Buy |
+76,808
| New | +$329K | ﹤0.01% | 2613 |
|
|
2020
Q2 | – | Sell |
-208,396
| Closed | -$724K | – | 3121 |
|
|
2020
Q1 | $724K | Buy |
+208,396
| New | +$883K | ﹤0.01% | 2001 |
|
|
2019
Q2 | – | Sell |
-26,300
| Closed | -$373K | – | 2856 |
|
|
2019
Q1 | $373K | Buy |
26,300
+5,700
| +28% | +$75.3K | ﹤0.01% | 2437 |
|
|
2018
Q4 | $279K | Sell |
20,600
-1,100
| -5% | -$19.8K | ﹤0.01% | 2511 |
|
|
2018
Q3 | $482K | Sell |
21,700
-4,350
| -17% | -$91.5K | ﹤0.01% | 2406 |
|
|
2018
Q2 | $427K | Buy |
+26,050
| New | +$457K | ﹤0.01% | 2445 |
|
Other funds holding AMRX
TGA
RCMNY
Russell Investments Group's AMRX Position: Q2 2026 in Review
Russell Investments Group increased its Amneal Pharmaceuticals (AMRX) stake by 18% in Q2 2026, buying an estimated $724K and bringing the position to 350,429 shares worth $6.07M. The position accounts for 0.01% of the portfolio, ranked #1388.
Russell Investments Group first reported a position in AMRX in Q2 2018 and has held it in 29 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.
- Russell Investments Group held 350,429 shares of Amneal Pharmaceuticals worth $6.07M as of Q2 2026.
- Russell Investments Group bought 52,865 Amneal Pharmaceuticals shares in Q2 2026, an estimated $724K.
- Amneal Pharmaceuticals made up 0.01% of Russell Investments Group's portfolio in Q2 2026, its #1388 holding.
- Russell Investments Group first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 29 quarters since.
- 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.
Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.